Entries by aaron

Corticosteroids use reduces proteinuria but fails to delay ESKD in immunoglobulin A nephropathy: Study

Norway: In a cohort of Norwegian patients with immunoglobulin A nephropathy (IgAN), a recent retrospective cohort study showed no impact of corticosteroid therapy on progression to end-stage kidney disease (ESKD), although the therapy reduced proteinuria. Also, the treatment was associated with adverse effects. “Corticosteroid therapy did not affect the time from diagnosis until end-stage kidney […]

80 percent with TB have no persistent cough contrary to prevalent belief: Study

More than 80% of patients with tuberculosis, the world’s most deadly infection, do not have a persistent cough, despite this being seen as a key symptom of the disease. The infection is predominantly transmitted by coughing, but probably also through simply breathing. Research, led by Amsterdam UMC and the Amsterdam Institute for Global Heath and […]

Laparoscopic hepatectomy as effective as percutaneous radiofrequency ablation for treating small hepatocellular carcinoma: Study

Laparoscopic hepatectomy as effective as percutaneous radiofrequency ablation for treating small hepatocellular carcinoma suggests a study published in the BMC Surgery. The purpose of this study was to compare the long-term outcomes of laparoscopic hepatectomy (LH) and percutaneous radiofrequency ablation (PRFA) for the treatment of small hepatocellular carcinoma. They systematically searched PubMed, Embase, Web of […]

Zydus Lifesciences bags USFDA tentative nod for Edaravone Injection to treat amyotrophic lateral sclerosis

Ahmedabad: Zydus Lifesciences Limited has announced that the Company has received tentative approval from the United States Food and Drug Administration (USFDA) to manufacture and market Edaravone Injection, 30 mg/100 mL (0.3 mg/mL), Single-Dose Vial, (RLD: RADICAVA). Edaravone is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called […]

Unlocking the Future of Immunotherapy with Hybridoma Technology

The paper is seen in the American Journal of Biopharmacy and Pharmatceutical Sciences published by Scientific Scholar A focused and extremely specific treatments for a wide range of ailments, including cancer, autoimmune disorders, and infectious diseases, immunotherapeutics based on antibody and hybridoma technologies have completely changed the practice of medicine. By harnessing the immune system’s […]

Cirrhosis patients undergoing contrast-enhanced CT not at higher risk of incident AKI compared to controls, finds study

Intravenous iodinated contrast media (ICM) in cirrhosis patients may cause nephrotoxicity, but research is limited and based on small, heterogeneous studies. According to a recent study published in the Journal of Hepatology, researchers concluded that The risk of acute kidney injury (AKI) following contrast-enhanced computed tomography (CECT) in patients with cirrhosis is relatively low and […]